Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Heavy chain diseases.

Wahner-Roedler DL, Kyle RA.

Best Pract Res Clin Haematol. 2005;18(4):729-46. Review.

PMID:
16026747
2.

[Heavy chain diseases].

Seligmann M.

Rev Prat. 1993 Feb 1;43(3):317-20. Review. French.

PMID:
8502962
3.

[Heavy chain disease].

Nomura S, Kanoh T.

Nihon Rinsho. 1995 Mar;53(3):730-5. Review. Japanese.

PMID:
7699914
4.

Mu-heavy chain disease: presentation as a benign monoclonal gammopathy.

Wahner-Roedler DL, Kyle RA.

Am J Hematol. 1992 May;40(1):56-60. Review.

PMID:
1566748
5.

Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature.

Fermand JP, Brouet JC, Danon F, Seligmann M.

Medicine (Baltimore). 1989 Nov;68(6):321-35. Review.

PMID:
2509855
6.

Heavy chain disease.

Witzig TE, Wahner-Roedler DL.

Curr Treat Options Oncol. 2002 Jun;3(3):247-54. Review.

PMID:
12057070
7.

Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.

Cheng IK, Ho SK, Chan DT, Ng WK, Chan KW.

Am J Kidney Dis. 1996 Aug;28(2):283-8. Review.

PMID:
8768927
8.

[gamma-heavy chain production as an epiphenomenon in non-Hodgkin's lymphoma].

Orth HB, Hurwitz N, Lohri A, Weber W, Herrmann R.

Dtsch Med Wochenschr. 1994 Sep 16;119(37):1235-8. Review. German.

PMID:
7924908
9.

Immunobiology and pathogenesis of alpha chain disease.

Seligmann M.

Ciba Found Symp. 1977 Apr 26-28;(46):263-81. Review.

PMID:
416936
10.

The heavy chain diseases: clinical and pathologic features.

Bianchi G, Anderson KC, Harris NL, Sohani AR.

Oncology (Williston Park). 2014 Jan;28(1):45-53. Review.

11.

Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.

Yanai M, Maeda A, Watanabe N, Sugimoto N, Matsushita A, Nagai K, Oida T, Takahashi T.

Int J Hematol. 2004 Feb;79(2):174-7. Review.

PMID:
15005347
12.

Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.

Ria R, Dammacco F, Vacca A.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018011. doi: 10.4084/MJHID.2018.011. eCollection 2018. Review.

13.

Lymphocytic lymphoma with associated gamma heavy chain and IgM-lambda paraproteins. An unusual biclonal gammopathy.

Presti BC, Sciotto CG, Marsh SG.

Am J Clin Pathol. 1990 Jan;93(1):137-41. Review.

PMID:
2104738
14.

Heavy-chain diseases.

Fermand JP, Brouet JC.

Hematol Oncol Clin North Am. 1999 Dec;13(6):1281-94. Review.

PMID:
10626151
15.

B-cell receptors and heavy chain diseases: guilty by association?

Corcos D, Osborn MJ, Matheson LS.

Blood. 2011 Jun 30;117(26):6991-8. doi: 10.1182/blood-2011-02-336164. Epub 2011 Apr 20. Review.

16.

Composite nodular lymphocyte-predominance Hodgkin disease and gamma-heavy-chain disease: a case report and review of the literature.

Hudnall SD, Alperin JB, Petersen JR.

Arch Pathol Lab Med. 2001 Jun;125(6):803-7. Review.

PMID:
11371236
17.

Pathological study of alpha-chain disease, with special emphasis on evolution.

Galian A, Lecestre MJ, Scotto J, Bognel C, Matuchansky C, Rambaud JC.

Cancer. 1977 May;39(5):2081-101. Review.

PMID:
404026
18.

Alpha-chain disease.

Rambaud JC, Seligmann M.

Clin Gastroenterol. 1976 May;5(2):341-58. Review. No abstract available.

PMID:
828567
19.

A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.

Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J.

Intern Med. 2010;49(14):1411-5. Epub 2010 Jul 15. Review.

20.

[Alpha heavy chain disease].

Teulières JP, Lambert R, Vachon A.

Sem Hop. 1978 May;54(13-16):546-53. Review. French.

PMID:
211601

Supplemental Content

Support Center